Hi, Matt Clifton (Novartis) and I (Joe Patel, C4 Therapeutics) are organising a session around the impact structural methods have had in the field of targeted protein degradation at this year's virtual ACA meeting.
The session is scheduled from 12pm till 3pm EDT on 5th August 2021 and we expect to run the talks live rather than pre-recorded. The abstract submission deadline is fast approaching and we would love to see more abstract submissions on this exciting facet of the drug discovery paradigm. The link to this year's meeting is below and our session is 3.2.3: https://www.acameeting.com/ Please note that abstract submission does require you to be a current paid up member of the ACA. Looking forward to an opportunity to promote and share the exciting structural research this field has delivered. Regards, Joe & Matt ________________________________ C4 Therapeutics, Inc. Confidentiality Notice: This message is private and may contain confidential and proprietary information. If you have received this message in error, please notify us and remove it from your system and note that you must not copy, distribute or take any action in reliance on it. Any unauthorized use or disclosure of the contents of this message is not permitted and may be unlawful. ######################################################################## To unsubscribe from the CCP4BB list, click the following link: https://www.jiscmail.ac.uk/cgi-bin/WA-JISC.exe?SUBED1=CCP4BB&A=1 This message was issued to members of www.jiscmail.ac.uk/CCP4BB, a mailing list hosted by www.jiscmail.ac.uk, terms & conditions are available at https://www.jiscmail.ac.uk/policyandsecurity/
